• Home
  • Pipeline
      • Back
      • PTX-COVID19-B
      • PTX-COVID19-LT
      • PTX-101 - Proposed mRNA Cancer Program
  • Technology
  • About
      • Back
      • Meet the Team
      • Foundations of Providence
      • Address to Canada
  • News & Media
      • Back
      • Press Releases
      • Publications
      • Media
  • Business Development
  • Investors
  • Privacy Policy
  • Careers
Privacy PolicyCareers
Providence Therapeutics
  • Home
  • Pipeline
    • PTX-COVID19-B
    • PTX-COVID19-LT
    • PTX-101 - Proposed mRNA Cancer Program
  • Technology
  • About
    • Meet the Team
    • Foundations of Providence
    • Address to Canada
  • News & Media
    • Press Releases
    • Publications
    • Media
  • Business Development
  • Investors
  • Privacy Policy
  • Careers

Media

Image
Image
Calgary-based Providence Therapeutics recruits for vaccine trial, secures funding for bringing jabs to developing world

Calgary-based Providence Therapeutics recruits for vaccine trial, secures funding for bringing jabs to developing world

Written on December 29, 2021

Read more

Providence’s COVID-19 mRNA Vaccine Challenger Seen In Phase III In Q1

Providence’s COVID-19 mRNA Vaccine Challenger Seen In Phase III In Q1

Written on October 07, 2021

Read more

Providence Therapeutics

Useful Links

Privacy Policy
Careers
Linkedin Page

Contact Us

120 - 8832 Blackfoot Trail S.E.
Calgary, AB T2J 3J1
  •  
© 2022 Providence Therapeutics. All Rights Reserved.
Calgary Web Design by Blue Ocean